Active ingredientDiflunisalCat. No. P-D114-001CAS 22494-42-4Family · Pharmaceutical analytical standards
Diflunisal
A non-steroidal anti-inflammatory drug derived from salicylic acid, with two fluorine atoms, developed in 1971 in a search for more potent analogues of acetylsalicylic acid; it is used for pain, osteoarthritis and rheumatoid arthritis. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?Decades later it was found to stabilise transthyretin, a blood protein: in 2025 the European Union authorised it for hereditary transthyretin amyloidosis with polyneuropathy.
Go to the active ingredient →Active ingredientDiflunisalCat. No. P-D114-001CAS 22494-42-4
Active ingredientDiflunisal SulphateCat. No. P-D114-002CAS 101072-47-3
MetaboliteDiflunisal Acyl GlucuronideCat. No. P-D114-003CAS 58446-30-3
Isotopically labelledDiflunisal-d3Cat. No. P-D114-005CAS 1286107-99-0
ImpurityDiflunisal Impurity 1Cat. No. P-D114-006CAS 705564-12-1
ImpurityDiflunisal Impurity 2Cat. No. P-D114-007CAS 1258635-47-0
ImpurityDiflunisal Impurity 3Cat. No. P-D114-008CAS 1639462-15-9
ImpurityDiflunisal Ethyl EsterCat. No. P-D114-009CAS 126093-86-5
ImpurityDiflunisal Isopropyl EsterCat. No. P-D114-010CAS 1381777-24-7
ImpurityDiflunisal Methyl EsterCat. No. P-D114-011CAS 55544-00-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.